HEALTH RESEARCH PRIORITIES: LATE-STAGE PRECLINICAL DEVELOPMENT STUDIES

Listed on GrantGunner. Last checked 3 Nov 2026.

About this grant

Supports IND-enabling studies, safety pharmacology, and regulatory requirements to initiate clinical trials for gene therapies, biologics, and drugs. This opportunity is designed to accelerate the late-stage preclinical development of candidate therapeutic and preventative agents that address diseases with significant public health relevance in the Kingdom.

Who can apply

The applicant must be affiliated with a Saudi organization (academic, research, hospital, or business with research collaboration), hold a doctorate or equivalent, have publication history with at least 4 years of experience, and both Saudi citizens and non-Saudi residents are eligible.

Browse all open grants

More grants from Saudi National Institute of Health (Saudi NIH)